Literature DB >> 17177961

IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection.

G E A Brito-Melo1, V Peruhype-Magalhães, A Teixeira-Carvalho, E F Barbosa-Stancioli, A B F Carneiro-Proietti, B Catalan-Soares, J G Ribas, O A Martins-Filho.   

Abstract

Although it is believed widely that distinct patterns of the host immune response are associated with the outcome of chronic human T cell lymphotropic virus type 1 (HTLV-I) infection toward asymptomatic or symptomatic neurodegenerative myelopathy (HAM/TSP), the exact mechanism underlying these immunological events still remains unknown. In this study, we have evaluated the cytokine pattern [interleukin (IL)-12, interferon (IFN)-gamma, tumour necrosis factor (TNF)-alpha, IL-4 and IL-10] of innate and adaptive immunity cells present at the peripheral blood from non-infected (NI) and HTLV-I infected individuals [asymptomatic (AS), oligosymptomatic (OL) and HAM/TSP-HT], following in vitro short-term incubation in the absence/presence of phorbol myristate acetate (PMA) pan-leucocyte stimulation. In the absence of PMA stimulation, our data demonstrate that despite the overall immunological profile of AS mimicry that observed for NI, the high frequency of IL-12(+) neutrophils and TNF-alpha(+) monocytes are also a hallmark of this group of individuals. However, the outstanding positive correlation between the high frequency of TNF-alpha(+) monocytes and high levels CD4(+) IL-10(+) and CD8(+) IL-10(+) T cells suggests the establishment of immunoregulatory mechanisms that guarantee their asymptomatic clinical status. On the other hand, OL and HT did not present any association between the high frequency and TNF-alpha(+) neutrophils and monocytes and this immunoregulatory profile at their adaptive immunity cells. Upon PMA-index analysis, high levels of type 1 CD4(+) T cells, as well as higher IFN-gamma/IL-10 and TNF-alpha/IL-10 ratios, were observed in HT, and re-emphasize the role of Th1-cytokines from CD4(+) cells to HTLV-I immunity and disease. Moreover, increasing frequency of CD8(+) IFN-gamma(+) and CD8(+) TNF-alpha(+) cells were observed in the HT, which corroborates the marked inflammatory profile underlying this pathological condition and the role of CD8(+) T cells in the pathogenesis of HAM/TSP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17177961      PMCID: PMC1810436          DOI: 10.1111/j.1365-2249.2006.03252.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Increased replication of HTLV-I in HTLV-I-associated myelopathy.

Authors:  M Yoshida; M Osame; H Kawai; M Toita; N Kuwasaki; Y Nishida; Y Hiraki; K Takahashi; K Nomura; S Sonoda
Journal:  Ann Neurol       Date:  1989-09       Impact factor: 10.422

2.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

3.  Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination?

Authors:  G R Moore; U Traugott; L C Scheinberg; C S Raine
Journal:  Ann Neurol       Date:  1989-10       Impact factor: 10.422

4.  Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy.

Authors:  F Umehara; S Izumo; A T Ronquillo; K Matsumuro; E Sato; M Osame
Journal:  J Neuropathol Exp Neurol       Date:  1994-01       Impact factor: 3.685

5.  The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group.

Authors:  M Popovic; M S Reitz; M G Sarngadharan; M Robert-Guroff; V S Kalyanaraman; Y Nakao; I Miyoshi; J Minowada; M Yoshida; Y Ito; R C Gallo
Journal:  Nature       Date:  1982-11-04       Impact factor: 49.962

6.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

7.  Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Authors:  Amir H Sabouri; Mineki Saito; Alun L Lloyd; Alison M Vine; Aviva W Witkover; Yoshitaka Furukawa; Shuji Izumo; Kimiyoshi Arimura; Sara E F Marshall; Koichiro Usuku; Charles R M Bangham; Mitsuhiro Osame
Journal:  J Infect Dis       Date:  2004-08-31       Impact factor: 5.226

8.  Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis.

Authors:  S Jacobson; V Zaninovic; C Mora; P Rodgers-Johnson; W A Sheremata; C J Gibbs; C Gajdusek; D E McFarlin
Journal:  Ann Neurol       Date:  1988       Impact factor: 10.422

9.  Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy.

Authors:  Y Kuroda; M Matsui
Journal:  J Neuroimmunol       Date:  1993-02       Impact factor: 3.478

10.  Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers.

Authors:  Silvane Braga Santos; Aurélia Fonseca Porto; André Luiz Muniz; Amélia Ribeiro de Jesus; Elza Magalhães; Ailton Melo; Walderez O Dutra; Kenneth J Gollob; Edgar M Carvalho
Journal:  BMC Infect Dis       Date:  2004-03-02       Impact factor: 3.090

View more
  13 in total

1.  Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation.

Authors:  Alfonso Eirin; Xiang-Yang Zhu; Amrutesh S Puranik; Hui Tang; Kelly A McGurren; Andre J van Wijnen; Amir Lerman; Lilach O Lerman
Journal:  Kidney Int       Date:  2017-02-24       Impact factor: 10.612

Review 2.  Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.

Authors:  Denise Utsch Gonçalves; Fernando Augusto Proietti; João Gabriel Ramos Ribas; Marcelo Grossi Araújo; Sônia Regina Pinheiro; Antônio Carlos Guedes; Anna Bárbara F Carneiro-Proietti
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Association of Tuberculosis Status with Neurologic Disease and Immune Response in HTLV-1 Infection.

Authors:  Anselmo Souza; Natália Carvalho; Yuri Neves; Silvane Braga Santos; Maria de Lourdes Bastos; Sérgio Arruda; Eduardo Martins Netto; Marshall J Glesby; Edgar Carvalho
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-26       Impact factor: 2.205

Review 4.  HTLV-1, Immune Response and Autoimmunity.

Authors:  Juarez A S Quaresma; Gilberto T Yoshikawa; Roberta V L Koyama; George A S Dias; Satomi Fujihara; Hellen T Fuzii
Journal:  Viruses       Date:  2015-12-24       Impact factor: 5.048

5.  Interactions between inflammatory gene polymorphisms and HTLV-I infection for total death, incidence of cancer, and atherosclerosis-related diseases among the Japanese population.

Authors:  Tara Sefanya Kairupan; Rie Ibusuki; Motahare Kheradmand; Yasuko Sagara; Eva Mariane Mantjoro; Yora Nindita; Hideshi Niimura; Kazuyo Kuwabara; Shin Ogawa; Noriko Tsumematsu-Nakahata; Yasuhito Nerome; Tetsuhiro Owaki; Toshifumi Matsushita; Shigeho Maenohara; Kazunari Yamaguchi; Toshiro Takezaki
Journal:  J Epidemiol       Date:  2017-05-30       Impact factor: 3.211

6.  MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications.

Authors:  Dominic Paquin-Proulx; Benjamin C Greenspun; Emanuela A S Costa; Aluisio C Segurado; Esper G Kallas; Douglas F Nixon; Fabio E Leal
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

7.  Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil.

Authors:  João Américo Domingos; Luana Silva Soares; Larissa M Bandeira; Camila Mareti Bonin; Ana C P Vicente; Louise Zanella; Marco Antonio Moreira Puga; Inês Aparecida Tozetti; Ana Rita Coimbra Motta-Castro; Rivaldo Venâncio da Cunha
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

Review 8.  Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases.

Authors:  Nicolas Futsch; Gabriela Prates; Renaud Mahieux; Jorge Casseb; Hélène Dutartre
Journal:  Viruses       Date:  2018-12-05       Impact factor: 5.048

9.  Immunological profile of HTLV-1-infected patients associated with infectious or autoimmune dermatological disorders.

Authors:  Jordana Grazziela Alves Coelho-dos-Reis; Livia Passos; Mariana Costa Duarte; Marcelo Grossi Araújo; Ana Carolina Campi-Azevedo; Andréa Teixeira-Carvalho; Vanessa Peruhype-Magalhães; Bruno Caetano Trindade; Raquel Dos Santos Dias; Marina Lobato Martins; Anna Barbara de Freitas Carneiro-Proietti; Antônio Carlos Guedes; Denise Utsch Gonçalves; Olindo Assis Martins-Filho
Journal:  PLoS Negl Trop Dis       Date:  2013-07-25

10.  Intratumoral TIGIT+ CD8+ T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer.

Authors:  Zhaopei Liu; Quan Zhou; Zewei Wang; Hongyu Zhang; Han Zeng; Qiuren Huang; Yifan Chen; Wenbin Jiang; Zhiyuan Lin; Yang Qu; Ying Xiong; Qi Bai; Yu Xia; Yiwei Wang; Li Liu; Yu Zhu; Le Xu; Bo Dai; Jianming Guo; Jiajun Wang; Yuan Chang; Weijuan Zhang
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.